Divergent Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
- Revenue Growth 21.75%
- Profit Growth 24.14%
- Ebitda 15.64%
- Net Worth 13.22%
- Total Assets -5.07%
About Divergent Pharmaceuticals
Divergent Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 June 2015 (Nine years and seven months 23 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 M.
Chhote Patel and Akhilesh Tripathi serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MP2015PTC034367
-
Company No.
034367
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jun 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Divergent Pharmaceuticals Private Limited offer?
Divergent Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Divergent Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chhote Patel
|
Director | 24-Jun-2015 | Current |
|
Akhilesh Tripathi
|
Director | 24-Jun-2015 | Current |
Financial Performance of Divergent Pharmaceuticals.
Divergent Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.75% increase. The company also saw a substantial improvement in profitability, with a 24.14% increase in profit. The company's net worth Soared by an impressive increase of 13.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Divergent Pharmaceuticals?
In 2023, Divergent Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Divergent Health Care Private LimitedAkhilesh Tripathi is a mutual person
Charges (Loans)
₹1.10 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2018 | Indian Overseas Bank | ₹1.10 M | Open |
How Many Employees Work at Divergent Pharmaceuticals?
Unlock and access historical data on people associated with Divergent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divergent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divergent Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
